Paul B. Card
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines.
Journal: Therapeutic advances in medical oncology
Published: August 27, 2021
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 13, 2021
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
Journal: Journal of the National Cancer Institute
Published: May 25, 2020
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2019
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: January 09, 2019
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Journal: Current oncology (Toronto, Ont.)
Published: November 23, 2018
The role of cytology in molecular testing and personalized medicine in lung cancer: A clinical perspective.
Journal: Cancer cytopathology
Published: September 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026